| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152918 Identifying whether an egg at day eleven of incubation (day-11) contains a live embryo by illuminaion with light from a light emitting diode (LED) at 650 nm-850 nm, injecting live egg with flu virus and harvesting amniotic fluid which has flu vaccine |
| 07/14/2005 | US20050152910 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 07/14/2005 | US20050152909 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152876 administering PTX3 to increase the amount or activity of Pentraxin 3 in the cumulous oophorus and/or the extracellular matrix of the cumulous oophorus |
| 07/14/2005 | US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 07/14/2005 | US20050152836 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 07/14/2005 | US20050152432 Method and apparatus for testing cement slurries |
| 07/14/2005 | US20050151973 Optical device utilizing plasmon resonance |
| 07/14/2005 | US20050151968 Systems and methods for continuous, on-line, real-time surveillance of particles in a fluid |
| 07/14/2005 | US20050151306 Method and apparatus for universal metallurgical simulation and analysis |
| 07/14/2005 | US20050151148 Sensors |
| 07/14/2005 | US20050150779 Reduced moisture compositions comprising an acid gas and a matrix gas, articles of manufacture comprising said compositions, and processes for manufacturing same |
| 07/14/2005 | US20050150778 Poly(valeryl-iminoethylene), polyethylenimine, polyallylamine, polyvinylamine, polyhistidine, polyornithine, polylysine, or polyarginine; and gold, silver, copper, platinum or gold-copper; detecting bacterial diseases; odor detection; computers; sampling urine, breath, blood, feces, vaginal discharge |
| 07/14/2005 | US20050150306 Method for verifying quality |
| 07/14/2005 | US20050150288 Measuring device |
| 07/14/2005 | US20050150278 Pavement material microwave density measurement methods and apparatuses |
| 07/14/2005 | US20050150273 Overburden rock core sample containment system |
| 07/14/2005 | EP1567637A3 Microreactor architecture and methods |
| 07/14/2005 | DE202005007144U1 Cooking oil or fat testing device is configured so that a fictitious polar fraction can be assigned to the dielectric constant of a test oil that has no actual polar content, to permit subsequent testing for calibration drift |
| 07/14/2005 | DE10361927A1 Ion canal for the development of pharmacological active ingredients, the detection of nerve gas or environmental toxins, comprises a sensor with a perforated substrate layer sandwiched between layers with micro channels |
| 07/14/2005 | DE10361243A1 Untersuchungsverfahren zur Phagozytose Investigation process of phagocytosis |
| 07/14/2005 | DE10359715A1 Verfahren und Prüfmittel zur Erfassung der Dichteverhältnisse oder der Aktivitätsverhältnisse von Elektrolyten in Lösung Procedures and test equipment to detect the density ratios or the activity ratios of electrolytes in solution |
| 07/14/2005 | DE10358775A1 Probennahmeeinrichtung und System zur Untersuchung von Probenflüssigkeit Sampling device and system for the investigation of sample liquid |
| 07/14/2005 | DE10352924A1 Vorrichtung und Verfahren zur qualitativen und/oder quantitativen Analyse von Inhaltsstoffen in Flüssigkeiten, insbesondere in Getränke- und Prozessflüssigkeiten Apparatus and method for the qualitative and / or quantitative analysis of ingredients in liquids, especially in beverage and process fluids |
| 07/14/2005 | DE10255282B4 Sonde zur Ermittlung der Sauerstoffaktivität von Metallschmelzen und Verfahren zu ihrer Herstellung Probe for determining the oxygen activity of metal melts and processes for their preparation |
| 07/14/2005 | CA2592504A1 Classification of cancer |
| 07/14/2005 | CA2552372A1 A process for preparing egg yolk antibodies |
| 07/14/2005 | CA2552208A1 Detection cartridges, modules, systems and methods |
| 07/14/2005 | CA2551920A1 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | CA2551912A1 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 07/14/2005 | CA2551560A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | CA2551553A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | CA2551259A1 A process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 07/14/2005 | CA2551110A1 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | CA2551097A1 Agonist anti-trkc antibodies and methods using same |
| 07/14/2005 | CA2550996A1 Methods for generating multimeric molecules |
| 07/14/2005 | CA2550962A1 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 07/14/2005 | CA2550933A1 Methods for identifying functional antibodies |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2550455A1 Haemophilus influenzae type iv pili |
| 07/14/2005 | CA2550316A1 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | CA2549948A1 Method for the identification of compounds modulating reverse transport of cholesterol |
| 07/14/2005 | CA2549829A1 Biomarkers for sensitivity of proliferative diseases to mtor inhibitors |
| 07/14/2005 | CA2546147A1 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 07/14/2005 | CA2545722A1 Methods of treating asthma |
| 07/14/2005 | CA2541135A1 Methods and kits for predicting an infectious disease state |
| 07/13/2005 | EP1553515A1 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 07/13/2005 | EP1553512A1 Information processing system using base sequence relevant information |
| 07/13/2005 | EP1553415A1 Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an activated carboxyl group on a surface thereof and microarray produced using the method |
| 07/13/2005 | EP1553414A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 07/13/2005 | EP1553413A1 Substrate for bioassay, substrate information reader, and substrate information reading method |
| 07/13/2005 | EP1553412A1 Method of inhibiting nonspecific interaction between molecules on solid phase support |
| 07/13/2005 | EP1553411A1 Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assesing body odor |
| 07/13/2005 | EP1553410A1 Apparatus for immunoassays and application thereof |
| 07/13/2005 | EP1553401A1 Raman spectroscopy method and device |
| 07/13/2005 | EP1553400A1 Method of detecting test bodies |
| 07/13/2005 | EP1553399A1 Body fluid components measuring apparatus and method |
| 07/13/2005 | EP1553395A1 Blood analyzer and method of separating plasma |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553188A1 Use of 4-galactosyl-xylose in humans for the in vivo evaluation of intestinal lactase as a non-invasive diagnostic test of the deficiency of said enzyme |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553180A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553078A1 Calcium receptor-active compounds |
| 07/13/2005 | EP1552887A2 Device and method for printing biomolecules onto substrate using electrohydrodynamic effect |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552790A1 Device for analysis of biochemical processes or molecules on the oral mucosa |
| 07/13/2005 | EP1552741A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/13/2005 | EP1552475A1 Chemical synthesis using diffraction grating-based encoded optical elements |
| 07/13/2005 | EP1552472A2 Methods and systems to identify operational reaction pathways |
| 07/13/2005 | EP1552463A2 Tool for in vitro-in vivo correlation |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552312A1 Diagnostic device for rapid determination of buprenorphine |
| 07/13/2005 | EP1552311A1 Method for detecting a risk of acid related disease in an individual |
| 07/13/2005 | EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 07/13/2005 | EP1552309A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 07/13/2005 | EP1552308A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 07/13/2005 | EP1552307A1 Diagnosis of glaucoma by complex autoantibody repertoires in body fluids |
| 07/13/2005 | EP1552306A1 Accessible assay device and method of use |
| 07/13/2005 | EP1552305A2 Polypeptide immobilization |
| 07/13/2005 | EP1552304A2 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 07/13/2005 | EP1552303A2 Biosensor |
| 07/13/2005 | EP1552302A2 Protein interaction difference mapping |
| 07/13/2005 | EP1552301A2 Methods of screening cyclic peptides and identifying targets therefor |
| 07/13/2005 | EP1552300A2 Sets of digital antibodies directed against short epitopes, and methods using same |
| 07/13/2005 | EP1552299A2 Method for the identification of ligands |
| 07/13/2005 | EP1552298A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 07/13/2005 | EP1552297A2 Improved methods for performing differential capture proteomics |
| 07/13/2005 | EP1552296A1 Population pharmacokinetic modeling |
| 07/13/2005 | EP1552295A2 Conformational sampling by self-organization |
| 07/13/2005 | EP1552294A1 Systems and methods for constructing genomic-based phenotypic models |
| 07/13/2005 | EP1552293A2 Gene segregation and biological sample classification methods |
| 07/13/2005 | EP1552292A1 Method for on-line monitoring of quality and condition of non-aqueous fluids |
| 07/13/2005 | EP1552291A2 Method for online measurement of molten phases |
| 07/13/2005 | EP1552290A2 Method and device for determining the sheen of rice |